|
|
|
|
|
|
|
Catalyst Pharm Inc (CPRX)
|
|
3.34 0 (0%)
|
05-18 16:00
|
|
Open:
|
3.36
|
Pre. Close:
|
3.34
|
|
High:
|
3.37
|
Low:
|
3.28
|
|
Volume:
|
312,355
|
Market Cap:
|
343M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.375 - 3.392
|
3.392 - 3.406
|
|
Low:
|
3.241 - 3.259
|
3.259 - 3.274
|
|
Close:
|
3.314 - 3.342
|
3.342 - 3.365
|
|
|
|
Technical analysis (as of: 2018-05-18 4:32:10 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 4.09 One year: 4.77
|
|
Support:
|
Support1: 2.86 Support2: 2.46
|
|
Resistance:
|
Resistance1:
3.50 Resistance2: 4.09
|
|
Pivot:
|
2.98 
|
|
Moving Averages:
|
MA(5): 3.34 MA(20): 2.91
MA(100): 3.14  MA(250): 2.99
|
|
MACD:
|
MACD(12,26):
0.17 Signal(12,26,9): 0.10
|
|
%K %D:
|
%K(14,3): 81.16 %D(3): 83.52
|
|
RSI:
|
RSI(14): 72.28
|
|
52-Week:
|
High: 4.51
Low: 2.02 Change(%): 59.8
|
|
Average Vol(K):
|
3-Month: 80479
10-Days 95423
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.CPRX has closed below upper band by 15.7%. Bollinger Bands are 97.4% wider than normal. The large width of the bands suggest high volatility as compared to CPRX's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-05-10T10:20:05-04:00
Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q1 2018 Results - Earnings Call Transcript
2018-05-09T16:24:14-04:00
Catalyst Pharmaceutical EPS in-line
2018-04-30T19:02:33-04:00
Institutional Investors Give Their Vote Of Confidence For Catalyst Pharmaceuticals
2018-04-19T11:05:40-04:00
Enrollment underway in late-stage study of Catalyst Pharma's Firdapse in subtype of myasthenia gravis
2018-04-04T12:41:46-04:00
Midday Gainers / Losers (4/4/2018)
2018-04-03T08:00:00-04:00
3 Things In Biotech, April 2: Catalyst Pharm Goes, Pfizer Flows, MediciNova Woes
2018-03-31T09:55:20-04:00
Week 14 Breakout Forecast: Short-Term Picks To Give You An Edge
2018-03-30T08:00:00-04:00
Your Daily Pharma Scoop: Heron Offering, Sorrento Issues Letter To Shareholders, MediciNova Setback
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
